The promise of tirzepatide: A narrative review of metabolic benefits
Primary Care Diabetes · 2025-06 · 19 (3) · 229-237
DOI: 10.1016/j.pcd.2025.03.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Primary Care Diabetes, 2025-06. Verfasst von Sara Sokary und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Nutrition, College of Health Science, QU-Health, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Weight Loss, Blood Glucose. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Library.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Nutrition, College of Health Science, QU-Health, Qatar University, Doha, Qatar.
- Department of Human Nutrition, College of Health Science, QU-Health, Qatar University, Doha, Qatar. Electronic address: hbawadi@qu.edu.qa.
Förderung
- Qatar National Library
Zitieren
APA
Sokary, S., & Bawadi, H. (2025). The promise of tirzepatide: A narrative review of metabolic benefits. Primary Care Diabetes, 19(3), 229-237. https://doi.org/10.1016/j.pcd.2025.03.008
Vancouver
Sokary S, Bawadi H. The promise of tirzepatide: A narrative review of metabolic benefits. Primary Care Diabetes. 2025;19(3):229-237. doi:10.1016/j.pcd.2025.03.008
BibTeX
@article{Sokary2025,
author = {Sokary, Sara and Bawadi, Hiba},
title = {The promise of tirzepatide: A narrative review of metabolic benefits},
journal = {Primary Care Diabetes},
year = {2025},
volume = {19},
number = {3},
pages = {229--237},
doi = {10.1016/j.pcd.2025.03.008}
}
EUVIMED